Loading company…
RenalSense develops medical devices for real-time monitoring of kidney function.
Founded in 2010 and based in Jerusalem, RenalSense makes monitoring technology for hospitals and healthcare providers treating kidney disease and acute kidney injury. In November 2021, it raised USD 14.00 mn in Series A funding led by BlueRed Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in